Myriad Genetics
MYGN
Rank 3335
Country USA
Exchange NASDAQ
Currency USD
Sector LIFE SCIENCES
Industry IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Address 320 WAKARA WAY, SALT LAKE CITY, UT, US
Myriad Genetics - Key figures
Market cap 1.52 Billion
Revenue 682.4 Million
Profit 493 Million
P/E Ratio No information
P/s Ratio 2.231
Myriad Genetics - Description
Myriad Genetics, Inc., a molecular diagnostics company, develops and markets predictive, personalized, and prognostic medicine tests in the United States and internationally.
The company is headquartered in Salt Lake City, Utah.